Bio-Technology General Euflexxa 1% Sodium Hyaluronate

País: Singapur

Idioma: anglès

Font: HSA (Health Sciences Authority)

Disponible des:

FERRING PHARMACEUTICALS PRIVATE LIMITED

clase:

Class D medical device

Fabricat per:

Bio-Technology General (Israel) Ltd.

Área terapéutica:

Orthopaedics

indicaciones terapéuticas:

EUFLEXXA is indicated for the treatment of pain caused by osteoarthritis of the knee, hip, temporomandibular, carpometacarpal, shoulder and ankle joints. EUFLEXXA aids in lubrication of the joint, allows for greater mobility and flexibility of the treated joint, and reduces pain in the affected joint.

Resumen del producto:

Device System Info:[Sterile Medical Device], EUFLEXXA is packed in a single-use, aseptically-filled disposable sterile 2.25 ml syringe (nominal volume) containing either 1 ml or 2 ml of 1% microbial fermentation-derived NaHA in phosphate-buffered saline; Models: Euflexxa 1% Sodium Hyaluronate - 3 x 2ml, Euflexxa 1% Sodium Hyaluronate - 1 x 2ml

Data d'autorització:

2017-04-28